Found: 5
Select item for more details and to access through your institution.
Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2020, p. 1, doi. 10.1155/2020/5956940
- By:
- Publication type:
- Article
The Score Model Containing Chinese Medicine Syndrome Element of Blood Stasis Presented a Better Performance Compared to APRI and FIB-4 in Diagnosing Advanced Fibrosis in Patients with Chronic Hepatitis B.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2016, v. 2016, p. 1, doi. 10.1155/2016/3743427
- By:
- Publication type:
- Article
Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B—A Retrospective Cohort Study.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 2311, doi. 10.2147/DMSO.S369824
- By:
- Publication type:
- Article
Impact of Metabolic Dysfunction Associated Fatty Liver Disease on the Prognosis of Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma Based on Propensity Score Matching Analysis.
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 2193, doi. 10.2147/CMAR.S368366
- By:
- Publication type:
- Article
Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patients.
- Published in:
- BMC Complementary & Alternative Medicine, 2016, v. 16, p. 1, doi. 10.1186/s12906-016-1486-1
- By:
- Publication type:
- Article